On the latest episode of “The Jimmy Dore Show,” comedian and political commentator Jimmy Dore highlighted the similarities between Pfizer’s expensive new antiviral drug for COVID and ivermectin, a generic drug used to treat the virus.
“I’ve never seen the propaganda machine so hard at work as it’s been against ivermectin,” said Dore. “Ivermectin won a Nobel Prize for human medicine in 2015, but the media really has everyone believing it’s for horses.” Dore suggested the motivation behind the propaganda is profits.
Dore played a video of John Campbell, Ph.D., explaining how Pfizer’s antiviral and ivermectin treat COVID in “the exact same way.” Campbell told viewers Pfizer’s new antiviral drug shows very high levels of efficacy in preventing severe disease, hospitalization and death.
“But there’s another drug, which is generic, called ivermectin, which works in the exact same way as the Pfizer antiviral,” Campbell said. “And there is conclusive proof from the scientific literature that the modality of action of the two drugs is the same. Both of these drugs inhibit viral replication.”
Campbell showed the molecular structure of Pfizer’s new drug and compared it to the molecular shape of ivermectin. He conceded the two “are completely different looking molecules” which led him to conclude “it’s absolutely fine to patent” the Pfizer drug.
“So they’re going to be able to make a lot of money out of it for the next 20 years,” he said.
Campbell cited a number of scientific papers which highlighted ivermectin’s effectiveness as an antiviral against COVID, including:
- A paper from the Royal Society of Chemistry which concluded ivermectin exhibits “inhibition” to the “catalytic activity” which causes COVID to replicate.
- An article in Nature which found that out of the 13 off-target drugs tested by researchers, only ivermectin blocked viral replication of SARS-CoV-2 by more than 80%.
- A paper from The Royal Society of Chemistry which showed ivermectin, out of dozens of drugs the researchers experimented with, had the “highest score” when it comes to to stopping viral replication of SARS-CoV-2. Notably, the paper showed that Remdesivir, which is currently patented and approved by the U.S. Food and Drug Administration, had the lowest score out of all of the compounds.
Campbell also pointed to a paper from Frontiers in Microbiology, which he said showed ivermectin not only attacked and bound to COVID’s spike protein which stopped it from infecting the cell, but also bound to the cell receptor.
“So it doesn’t just work one way, but two different ways,” explained Dore. “It double screws it up so you can’t get COVID.”
Campbell put it this way: “Not only does ivermectin bend the COVID key, but it also ruins the lock.”
Campbell told viewers:
“So as far as we’ve been told, the new Pfizer drug is only working against one particular biochemical pathway to stop COVID, and with ivermectin, it’s working against that same biochemical pathway to stop COVID but also several others.”
“Why don’t you know this?” Dore asked. “Because ivermectin is cheap, and we live in a world that is made up of corporate propaganda.”
Watch the segment here:
© 2021 Children’s Health Defense, Inc. This work is reproduced and distributed with the permission of Children’s Health Defense, Inc. Want to learn more from Children’s Health Defense? Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. Your donation will help to support us in our efforts.
One Sick Day Proves We Need More Voices in Truthful Media
On October 19, I was sick. It crossed my mind that I had finally gotten the ‘rona, but my wife’s cream of chicken soup and a few extra hours of sleep into mid-afternoon had be back up and running after a sleepless night before.
When I finally stumbled over to my computer in the evening, I was met with a deluge of concern from readers. They asked what had happened as only one article had been posted that day. Generally, we post between 10-20 daily between all of the sites, not included curated and aggregated content. Seeing that we’d only posted my super-early morning article before taking the rest of the day off had readers assuming the worst.
We have a wonderful and talented group of writers who volunteer their time for the sites and their readers. Sharing their amazing perspectives has always been a blessing to us because we cannot afford to hire anyone at this time. But having great writers is meaningless if we don’t have great editors, or at least one additional. My wife helps me read and edit stories from time to time, but I’m a one-man show when it comes to getting the stories posted.
Whenever I highlight our desperate need for donations, I note that we do not receive money from Google ads even though most in conservative media are beholden. I often ambiguously note that the money donated will help us grow. Today, I’m highlighting a specific need. We must get an editor to help take some of the load and to expand on our mission of spreading the truth to the world. One sick day proved that.
The great news is that there is no shortage of people who CAN help. I am emailed variations of resumes every week by people who are much smarter than I am. As much as I’d love to hire some of them, we simply cannot. That takes money and as blessed as we’ve been to receive donations and collect ad money (though not from Google or Facebook), we have still fallen short.
Those who have the means, PLEASE consider donating. We have the standard Giving Fuel option and people can donate through PayPal. We are also diving into what we believe is extremely disruptive technology at LetsGo.finance, the world’s first major donation portal for crypto. I’ll be talking a lot more about them in the near future. Those who prefer Bitcoin can send to my address here: 3A1ELVhGgrwrypwTJhPwnaTVGmuqyQrMB8
We can get the voices out there and we’re willing to shine a spotlight on new talent. We just need the resources to make it happen. If you can help, we would be extremely grateful.
Thank you and God bless!
JD Rucker
All ORIGINAL content on this site is © 2021 NOQ Report. All REPUBLISHED content has received direct or implied permission for reproduction.
With that said, our content may be reproduced and distributed as long as it has a link to the original source and the author is credited prominently. We don’t mind you using our content as long as you help out by giving us credit with a prominent link. If you feel like giving us a tip for the content, we will not object!
JD Rucker – EIC
@jdrucker
